Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Despite improved outcomes with atezolizumab plus bevacizumab (A+B) in hepatocellular carcinoma (HCC), primary refractoriness (PRef), characterised by early progression or short-lived disease stabilisation following treatment, remains a significant challenge. METHODS: We analysed 1296 patients with HCC treated with frontline A+B (AB-real) and validated findings in 645 trial participants...
Accurate histologic subtyping, tumor node metastasis classification (TNM) staging and prognostic assessment are central to clinical management of non-small cell lung cancer (NSCLC), but remain challenging because of tumor heterogeneity, limited biomarker performance and diagnostic uncertainty. Here we show that a multimodal, multi-task deep learning scoring system (MM-DLS), integrating pretreatmen...
Early assessment of treatment response is essential for optimizing cancer management, as it allows timely interventions during the course of therapy, ...
Accurate characterization of thoracic malignancies on computed tomography (CT) remains challenging because histological subtype differentiation and no...
Accurate prognostic models are essential for optimizing treatment strategies in gallbladder adenocarcinoma (GBAC). We preliminarily constructed and va...
Aging is asynchronous across cells and organs. Here we tested whether plasma proteomics can be used to analyze cell type-specific aging. From analyses...
This study was aimed at evaluating the effectiveness of artificial intelligence (AI) in detecting jaw cysts and tumors, analyzing lesion content, and ...
Artificial intelligence (AI) algorithms such as ENLIGHT and DeepPT represent promising approaches to identify predictive biomarkers for immune checkpo...
Ovarian cancer, with high mortality, demands accurate preoperative assessment to guide individualized treatment. It typically requires ultrasound, CT,...
We performed deep learning analysis of histopathological whole-slide (full-face) images (WSI) to predict ATM pathogenic or likely pathogenic variant (...
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease (NAFLD), is the most prevalent ch...
BACKGROUND: Alcohol is a group 1 carcinogen linked to seven cancers, yet awareness of this risk remains low in the United State. Identifying effective...
Classic BCR::ABL1-negative myeloproliferative neoplasms (MPNs)-polycythaemia vera, essential thrombocythaemia, and primary myelofibrosis-are clonal ha...
Colorectal cancer (CRC) is closely associated with gut microbiota dysbiosis; however, comprehensive benchmarking of machine learning models that integ...
BACKGROUND: Computational prediction of drug-target interaction (DTI) is critical for drug discovery and precision medicine. Herein, we constructed a ...
Serum biomarkers for early cancer detection often suffer from limited sensitivity and specificity due to the biochemical complexity of blood. Here, we...
The Oncotype DX assay has revolutionized the management of early-stage, hormone receptor-positive, HER2-negative breast cancer. Developed in 2004, it ...
BACKGROUND: The study of cell-free circulating DNA (cirDNA) fragments (fragmentomics) from liquid biopsies has received increasing attention to detect...
The Australian Magnetic Resonance Imaging (MRI) Linear Accelerator program (MRI linac) was a major research project that aimed to build and test a uni...
Grade 4 glioma is inherently lethal due to inevitable recurrence. Current radiotherapy guidelines recommend uniform target volume margins, disregardin...